Pietro Santulli1, Diane de Villardi, Vanessa Gayet, Marie-Christine Lafay Pillet, Louis Marcellin, Valerie Blanchet, Julia Gonnot, Emmanuel Dulioust, Odile Launay, Charles Chapron. 1. aDepartment of Gynecology, Obstetrics II and Reproductive Medicine, Université Paris Descartes, Sorbonne Paris Cité, Faculté de Médecine, Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Universitaire (GHU) Ouest, Centre Hospitalier Universitaire (CHU) Cochin bDepartment 'Development, Reproduction and Cancer', Institut Cochin, INSERM U1016, Université Paris Descartes, Sorbonne Paris Cité cInstitut Cochin, Université Paris Descartes, Sorbonne Paris Cité CNRS (UMR 8104) dDepartment of Histology, Embryology, and Biology of Reproduction, Université Paris Descartes, Sorbonne Paris Cité, Faculté de Médecine, Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Universitaire (GHU) Ouest, Centre Hospitalier Universitaire (CHU) Cochin eUniversité Paris Descartes, Sorbonne Paris Cité, Faculté de Médecine, Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Universitaire (GHU) Ouest, Centre Hospitalier Universitaire (CHU) Cochin, Infectiologie, Paris, France. *Diane de Villardi and Pietro Santulli contributed equally to this work.
Abstract
OBJECTIVE: To evaluate HIV directly or indirectly related altered ovarian function, using serum anti-Müllerian hormone (AMH) levels in HIV-infected women as compared with seronegative women. DESIGN: We conducted a matched cohort study from January 2008 to December 2013 in a tertiary university centre. Two hundred and one HIV-infected women requesting assisted reproductive technology and 603 age and cause of infertility-matched HIV seronegative women were enrolled in this study. METHODS: All data were prospectively collected using a semistructured questionnaire. Serum AMH levels in HIV-infected women and matched controls were compared. To find out the contributing factors to increased serum AMH levels in HIV-infected women, a backward multiple linear regression was performed. RESULTS: Serum AMH levels were significantly lower in HIV-infected group as compared with seronegative controls (3.0 ± 2.8 vs 3.7 ± 3.5 ng/ml; respectively, P = 0.001). Looking for factors associated with altered AMH among HIV-infected women, an association has been shown between tubal disease and a further decrease in serum AMH levels (2.4 ± 2.4 vs 3.4 ± 3.0 ng/ml; respectively, P = 0.011). Among HIV-infected women, after multivariate linear regression analysis, we showed that increased age, BMI and viral load were associated with decreased serum AMH levels whereas in striking contrast an increase in CD4⁺ cell count was associated with an increase of serum AMH levels. CONCLUSION: Serum AMH levels were lower in the HIV-infected group than in the control group. Age, BMI, CD4⁺ cell count and viral load were the independent contributors affecting serum AMH levels among HIV-infected women.
OBJECTIVE: To evaluate HIV directly or indirectly related altered ovarian function, using serum anti-Müllerian hormone (AMH) levels in HIV-infectedwomen as compared with seronegative women. DESIGN: We conducted a matched cohort study from January 2008 to December 2013 in a tertiary university centre. Two hundred and one HIV-infectedwomen requesting assisted reproductive technology and 603 age and cause of infertility-matched HIV seronegative women were enrolled in this study. METHODS: All data were prospectively collected using a semistructured questionnaire. Serum AMH levels in HIV-infectedwomen and matched controls were compared. To find out the contributing factors to increased serum AMH levels in HIV-infectedwomen, a backward multiple linear regression was performed. RESULTS: Serum AMH levels were significantly lower in HIV-infected group as compared with seronegative controls (3.0 ± 2.8 vs 3.7 ± 3.5 ng/ml; respectively, P = 0.001). Looking for factors associated with altered AMH among HIV-infectedwomen, an association has been shown between tubal disease and a further decrease in serum AMH levels (2.4 ± 2.4 vs 3.4 ± 3.0 ng/ml; respectively, P = 0.011). Among HIV-infectedwomen, after multivariate linear regression analysis, we showed that increased age, BMI and viral load were associated with decreased serum AMH levels whereas in striking contrast an increase in CD4⁺ cell count was associated with an increase of serum AMH levels. CONCLUSION: Serum AMH levels were lower in the HIV-infected group than in the control group. Age, BMI, CD4⁺ cell count and viral load were the independent contributors affecting serum AMH levels among HIV-infectedwomen.
Authors: Anna Hachfeld; Andrew Atkinson; Alexandra Calmy; Begoña Martinez de Tejada; Barbara Hasse; Paolo Paioni; Christian R Kahlert; Noémie Boillat-Blanco; Marcel Stoeckle; Karoline Aebi-Popp Journal: HIV Med Date: 2021-09-02 Impact factor: 3.094
Authors: Markella V Zanni; Judith S Currier; Amy Kantor; Laura Smeaton; Corinne Rivard; Jana Taron; Tricia H Burdo; Sharlaa Badal-Faesen; Umesh G Lalloo; Jorge A Pinto; Wadzanai Samaneka; Javier Valencia; Karin Klingman; Beverly Allston-Smith; Katharine Cooper-Arnold; Patrice Desvigne-Nickens; Michael T Lu; Kathleen V Fitch; Udo Hoffman; Steven K Grinspoon; Pamela S Douglas; Sara E Looby Journal: J Infect Dis Date: 2020-07-09 Impact factor: 7.759
Authors: Pauline Vabre; Nicolas Gatimel; Jessika Moreau; Véronique Gayrard; Nicole Picard-Hagen; Jean Parinaud; Roger D Leandri Journal: Environ Health Date: 2017-04-07 Impact factor: 5.984
Authors: Clara E Van Ommen; Arianne Y K Albert; Micah Piske; Deborah M Money; Hélène C F Cote; Viviane D Lima; Evelyn J Maan; Ariane Alimenti; Julianne van Schalkwyk; Neora Pick; Melanie C M Murray Journal: PLoS One Date: 2019-02-06 Impact factor: 3.240